2025.10.23 (¸ñ)
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule
½Ã¸³¼ö¼Ã»¼Ò³â¼¾ÅÍ, 2025 Á¦4ȸ û¼Ò³â¸ÞÀÌÄ¿°æÁø´ëȸ ¡®YOUTH MAKER¡¯ ¼ºÈ²¸®¿¡ °³ÃÖ
TRM ·¦½º, ½Ì°¡Æ÷¸£ »çÀ̹öº¸¾Èû°ú Çù·ÂÇØ ºí·ÏüÀÎ ºÐ¾ß ±¹°¡ »çÀ̹ö À§Çù ÀÎÅÚ¸®Àü½º °È ÃßÁø
°æºÏ´ë Àι®»çȸÀ¶ÇÕÀÎÀç¾ç¼º»ç¾÷´Ü, ´ë±¸ÀüÅë½ÃÀåÁøÈïÀç´Ü°ú Çù·ÂÇØ ·ÎÄà ũ¸®¿¡ÀÌÅÍ ÀÎÀç ¾ç¼º
Aptiv Unveils Gen 8 Radars to Power the Future of ADAS